Although the role of HSP47 is unclear in IPF, inhibition of HSP47 (with a lipid nanoparticle encapsulating an siRNA against HSP47, ND-L02-s0201) has been shown to improve pulmonary fibrosis in phase I clinical trials50. Here, SERPINH1 is linked to idiopathic pulmonary fibrosis.